English
Investors
Shareholders
EQT logo
About
Teams
Sustainability
Investments
Media
Important notice
Current portfolio
T-Knife
T-knife is a biopharmaceutical company dedicated to developing novel therapeutics to fight cancer, initially focused on T cell receptor (TCR)
Sector
Healthcare
Country
Germany
Fund
LSP 6
Entry
2021
Web
t-knife.com
Sector
Healthcare
Country
Germany
Fund
LSP 6
Entry
2021
Web
t-knife.com
0
Investments
EQT logo